TV
Tuyl Christopher Van
Chief Legal Officer

Tuyl Christopher Van insider trades: Immunovant (IMVT) stock sales

Chief Legal Officer, Immunovant Last trade Oct 7, 2026 11 Form 4 filings
$1.5M
Sold, last 12 months
8 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2025
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Tuyl reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 7, 2026IMVT↓ Sell$43K
Sep 23, 2026IMVT↓ Sell$103K
Jul 8, 2026IMVT↓ Sell$48K
Jun 26, 2026IMVT↓ Sell$683K
Jun 18, 2026IMVT↓ Sell$93K
Apr 8, 2026IMVT↓ Sell$128K
Mar 18, 2026IMVT↓ Sell$72K
Dec 18, 2025IMVT↓ Sell$291K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other IMVT insiders

Open-market trades in the last 12 months

About Tuyl Christopher Van's insider trades

Tuyl Christopher Van is Chief Legal Officer at Immunovant (IMVT). Since Dec 18, 2025, Tuyl has reported no open-market purchases and 8 sales worth $1.5M on SEC Form 4. In the last 12 months: 8 sales ($1.5M).

Their filings also include grants and awards (3 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IMVT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.